Showing 1 - 4 results of 4 for search 'Katja Schlichtig', query time: 0.02s
Refine Results
-
1
Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center by Lisa Cuba, Katja Schlichtig, Pauline Dürr, Elisabeth C. Inwald, Martin F. Fromm, Frank Dörje
Published 2023-06-01
Article -
2
Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial by Pauline Dürr, Florian Meier, Katja Schlichtig, Anja Schramm, Lukas Schötz, Martin F. Fromm, Frank Dörje
Published 2022-10-01
Article -
3
New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial by Katja Schlichtig, Lisa Cuba, Pauline Dürr, Laura Bellut, Norbert Meidenbauer, Frank Kunath, Peter J. Goebell, Andreas Mackensen, Frank Dörje, Martin F. Fromm, Bernd Wullich
Published 2022-08-01
Article -
4
An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human Plasma by Niklas Kehl, Katja Schlichtig, Pauline Dürr, Laura Bellut, Frank Dörje, Rainer Fietkau, Marianne Pavel, Andreas Mackensen, Bernd Wullich, Renke Maas, Martin F. Fromm, Arne Gessner, R. Verena Taudte
Published 2021-12-01
Article